Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –

Slides:



Advertisements
Similar presentations
Treatment of Hypertension
Advertisements

1 CAMELOT: Study Design A Morbidity and Mortality Study Patients with documented CAD on standard-of-care therapies* (n=1997) Clinical events (morbidity.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
Assessment and Management of Patients With Hypertension.
CVD risk estimation and prevention: An overview of SIGN 97.
Classification of blood pressure for adults Category Blood Pressure (mmHg) Systolic Diastolic OptimalNormalHigh-normalHypertension Stage 1 Stage 1 Stage.
Cholesterol quintile (mg/dL)
1 1 ManagementofHypertension Introduction to Primary Care: a course of the Center of Post Graduate Studies in FM PO Box – Riyadh Tel:
HYPERTENSION Detection, Evaluation and Non-pharmacologic Intervention
BLOOD PRESSURE.  The difference between the systolic and diastolic pressure (approximately 40 mm Hg) is called the pulse pressure.
Heart Disease Map.
Diagnosis and Management of Hypertension Davin Haraway DO,FACOI,CWS Associate Professor of Medicine – OSU Center for Health Sciences.
Hypertension Dr. Meg-angela Christi Amores. Hypertension doubles the risk of cardiovascular diseases present in all populations except for a small number.
Epidemiology Prevalence Increase with age 25% of the white males vs. 17% in white females 44% of black males vs. 37% in black femals Indifference between.
Medical English “Hypertension” Presentation by group one Medical faculty of Wijaya Kusuma University.
In the Name of God In the Name of God Overview of Hypertension Mahboob Lessan Pezeshki MD Tehran University of Medical Sciences Aban 1392.
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
Hypertension: JNC 7 Guidelines Steven W Harris MHS PA-C.
Hypertension. Definition: blood pressure Blood pressure is the force of blood pushing through the arteries and is necessary for maintaining our circulation.
An Overview of the Clinical Pathophysiology of Hypertension, its Interpretation According to Tibb Philosophy and its Relationship with Temperament- Investigating.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
 Edmond 75 years presented with ‘shocking” blood pressure recordings of 184/102 in the morning. His afternoon and night readings were in the ‘acceptable.
Public Health. CVDDiabetesCancer Antibiotic Resistance.
FAME HTN Mohsen. Epidemiology and stuff  About 1/3 of middle aged patients have hypertension  About ½ of elderly patients have hypertension.  Responsible.
0CTOBER 2010 An Approach for Sub-Saharan Africa. Dr. Linda Hawker, MD, CCFP General Practice Kelowna BC Canada.
 Update on Hypertension Troy L. Randle, DO, FACC, FACOI.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Women & Heart Disease American Heart Association Greater Southeast Affiliate 0.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
HYPERTENSIVE CRISIS MOHAMMED R ARAFAH MBBS FACP FRCPC FACC PROFESSOR OF CARDIOLOGY.
Are you at Risk for a Stroke, Aneurysm or Peripheral Arterial Disease?
بیماریهای ادرنال. Endocrine Hypertension Hypertension (HT) is the most prevalent cardiovascular disorder and a major public health problem in the United.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
Primordial, primary, secondary, and tertiary prevention stages for global vascular risk. R. Sacco: Stroke, Volume 38(6).June
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Risk of hypertension (HTN) and non-drug management Aliakbar Tavassoli.
Radka Adlová Arterial hypertension and preventive cardiology.
Hypertension Dr. Gerrard Uy. Hypertension doubles the risk of cardiovascular diseases present in all populations except for a small number of individuals.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
 “The collective term for various forms of diseases of the heart and blood vessels.”  Examples?  Heart attack, coronary artery disease (CAD), hypertension,
Hypertension BP ≥140/90 (WHO/ISH,1993) Isolated systolic hypertension: BP syst ≥ 140 mm Hg, BP diast. < 90 mm Hg.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
HYPERTENSION. Problem Magnitude Hypertension( HTN) is the most common primary diagnosis in America. 35 million office visits are as the primary diagnosis.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Baseline characteristics. Patient flow Completed Completed Perindopril Placebo Randomised Not randomised Registered.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
HYPERTENSION Pathophysiology Dr. Zahoor Ali Shaikh 1.
Common Endocrine Disorders Dr Amanda Stewart Consultant Endocrinologist Tawam Hospital.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
1 1 ManagementofHypertension Introduction to Primary Care: a course of the Center of Post Graduate Studies in FM PO Box – Riyadh Tel:
Hypertension Catherine Florio Pipas, MD Community & Family Medicine 2007.
Internal Medicine Workshop Series Laos September /October 2009.
Objectives of Training To provide you with an overview of MSD Informatics Software. To provide you with sufficient training to be able to use MSD Informatics.
 50 million people USA  SBP>115 incr risk CAD/CVA  Pseudo-HTN  Secondary HTN 2.
Stroke “the brain attack”. Stroke Caused when blood flow to the brain is cut off There is a blockage in the arteries. That part of the brain suffocates.
FOURIER Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
HTN management in clinic and evaluation of secondary causes
Hypertension guidelines What’s all the controversy about 2015
Hypertension.
Judith H. Veis, MD, FACP Associate Director, Nephrology
HYPERTENSION.
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Prevention Cardiovascular disease
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Pathology Of Hypertension
Measuring Blood Pressure
Internal Medicine Workshop Series Laos September /October 2009
Presentation transcript:

Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension – Common? – Caused by  vascular resistance – Harmless??

Causes of secondary hypertension: Renal: Chronic parenchymal diseases (3-5%). Renal artery stenosis (1-2%).

Causes of secondary hypertension: Endocrinal: – Primary hyper aldosteronism< 0.3%. – Pheochromocytoma <0.3%. – Hypo or hyperthyroidism. – Cushing syndrome.

Causes of secondary hypertension: Aortic coartication. Drug induced. Pregnancy.

Aim of evaluation: Establishment of diagnoses. Assessment of CV risk. Evaluation of TOD. Diagnoses of secondary hypertension.

Patient Evaluation Hypertension Smoking Obesity Physical inactivity Dyslipidemia Diabetes Assess lifestyle and identify other CV risk factors or concomitant disorders:

Assess lifestyle and identify other CV risk factors or concomitant disorders Microalbuminuria or GFR < 60 ml/min Age – Males > 55 yrs – Females > 65 yrs Family history of CVD – Males < 55 yrs – Females < 65 yrs

Patient Evaluation Sleep Apnea Drug-induced Chronic kidney disease Primary aldosteronism Renal vascular disease Reveal identifiable causes of hypertension:

Chronic steroid therapy and Cushing’s syndrome Pheochromocytoma Coarctation of the aorta Thyroid or parathyroid disorders

Patient Evaluation Heart – LVH or CHF – Angina or prior MI – Prior coronary revascularization Brain – Stroke or transient ischemic attack (TIA) Assess the presence or absence of target organ damage and CVD

Chronic kidney disease Peripheral arterial disease Retinopathy